Bajaj Healthcare (BOM:539872) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:539872 Bajaj Healthcare Ltd BOM:539872
62 GF Score
Price ₹328.35
GF Value ₹409.71
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Bajaj Healthcare FFO?

FFO (Funds from operations) only applies to REITs.

BOM:539872
62GF Score
Bajaj Healthcare Ltd BOM:539872
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bajaj Healthcare (BOM:539872) Overvalued in 2026?

Based on GuruFocus' analysis, Bajaj Healthcare stock appears to be undervalued. The current stock price of ₹328.35 is trading 19.9% below its estimated GF Value™ of ₹409.71. GuruFocus considers Bajaj Healthcare to be Modestly Undervalued.

Key valuation signals for BOM:539872:

  • FFO:
  • GF Value™: ₹409.71 vs. price of ₹328.35 (19.9% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the BOM:539872 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bajaj Healthcare Business Description

Other Exchanges BAJAJHCARE:India
Address Road No. 23, Wagle Industrial Estate, 602-606, Bhoomi Velocity Infotech Park, Plot No. B-39, B-39A, B-39A/1, Thane (West), Thane, MH, IND, 400 604
Bajaj Healthcare Ltd is an India-based pharmaceutical company that manufactures Active Pharmaceutical Ingredients (APIs), Intermediates, Finished Dosage Forms, and Nutraceuticals. Its products include Intermediates, API, Formulation, and Impurities. The company derives a majority of its revenue from India.
62GF Score

Get the complete analysis for BOM:539872

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹328.35
Price
₹409.71
GF Value